Cholestasis after Kasai operation predicts portal hypertension in native liver survivors of biliary atresia: a multicenter study
Topic overview
Multicenter study of 320 biliary atresia patients found that 37.8% developed portal hypertension 5 years post-Kasai operation. Persistent cholestasis at 12 months (bilirubin >38 µmol/L) strongly predicts portal hypertension risk, with early surgery (<41 days) offering protective benefit for native liver survivors.
Key takeaways
- Early Kasai portoenterostomy (before day 41 of life) significantly reduces portal hypertension risk in biliary atresia survivors.
- Persistent cholestasis at 12 months post-Kasai strongly predicts portal hypertension development (OR=12.9).
- Bilirubin >38 µmol/L at 12 months post-Kasai identifies high-risk patients needing intensified surveillance (78% sensitivity).
- 37.8% of transplant-free biliary atresia patients develop portal hypertension by 5 years after Kasai operation.
- Patients with persistent jaundice one year post-Kasai require more vigilant long-term monitoring for portal hypertension complications.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Cholestasis after Kasai operation predicts portal hypertension in native liver survivors of biliary atresia: a multicenter study. GlobalCastMD Medical Library. 2024-07-17. https://dev.library.globalcastmd.com/article/8878?via_space=staycurrentmd
Comments